神経変性症の治療研究のためのミトファギーの可視化と調節
Hiroyuki Katayama1, Hiroshi Hama1, Koji Nagasawa2
1Laboratory for Cell Function Dynamics, RIKEN Center for Brain Science, 2-1 Hirosawa, Wako-City, Saitama 351-0198, Japan.
Cell
|May 22, 2020
まとめ
研究者はミトコンドリアの品質管理の正確な監視を可能にする新しいミトファジー指標であるミト-SRAIを開発しました. このツールは パーキンソン病のような病気の理解に 欠陥のあるミトコンドリアを 選択的に除去する化合物を特定しました
科学分野:
- 細胞生物学
- ミトコンドリア動力学
- 神経科学
背景:
- mitochondrial 機能障害は 多くの人間の病気に 関わっている.
- 損傷したミトコンドリアを除去するプロセスであるミトファギーは 細胞の品質管理の重要なメカニズムです
- 現存するミトファギーの探知器は特異性と定量的な正確性が欠けている.
研究 の 目的:
- ミトファギーの新しい定量指標を開発する.
- 損傷したミトコンドリアのミトファギーを選択的に誘導する化合物を特定する.
- パーキンソン病のモデルにおけるミトファギーの役割を調査する.
主な方法:
- 光タンパク質の行動に基づくミトファギーの指標であるミト-SRAIの発達.
- 複製可能なミトファギーのモニタリングのためのミトコンドリア標的の厳格な制御.
- ミトファギーを誘発する化合物を検出するための高通量画像ベースのスクリーニング.
主要な成果:
- mito-SRAIは,固定された生物学的サンプルで再現可能なミトファギーの監視を可能にします.
- 損傷したミトコンドリアのミトファギーを選択的に誘導する新しい化合物が発見されました.
- パーキンソン病のマウスモデルにおけるドーパミナージックニューロンはミトファギーの障害を示し,ニューロンの生存に影響を与えた.
結論:
- mito-SRAIは,定量的なミトファジー研究のための貴重なツールです.
- ミトコンドリア機能不全を伴う疾患の治療策としてミトファギーをターゲットにすることがあります.
- ミトファギーの障害はパーキンソン病の神経変性につながる.
関連する概念動画
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.4K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
603
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
603
Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Constipation-Predominant IBS
1.5K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.5K
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
681
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
681
Gut-Brain Axis
249
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
249


